**14.4 OPC-167832**

It is a derivative of 3,4-dihydrocarostyril. OPC-167832 is bactericidal and works by targeting DprE1, leading to the prevention of mycobacterial infection. It represents improved performance when in combination with delamide. Presently it falls under the category of phase 1 clinical studies [10, 15].
